Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by princeofcuton Aug 19, 2015 9:22am

64 Views

Post# 24030824

RE:RE:re: Leadership Matters discussion, ETC-1002 & Don

tarmac, how are those MOL skidmarks on your investing back??? they were chinee weren't they...but back to Li Li as best i can tell Li Li is down on RVX (significantly) whereas i am up on my RVX trading so maybe Li Li should be asking me for my advice???? and finally as a now proved pumpertrashole you faild (purposefully and fraudulently) to post the date and source of your post so i conclude like hoity toity you are making it up

Bullboard Posts

HPQ Silicon updates shareholders on Fumed Silica Reactor developments